DEVELOPMENT OF A COMBINATION THERAPY FOR PROSTATE CANCER BY TARGETING STAT3 AND HIF-1ALPHA

$689,393FY2010Department of DefenseDOD

Baylor College Of Medicine, Houston TX

Investigators

DEVELOPMENT OF A COMBINATION THERAPY FOR PROSTATE CANCER BY TARGETING STAT3 AND HIF-1ALPHA · GrantIndex